Investor Relations

iCo was awarded a Gold Leaf Award as the Early Stage Company of the Year from BIOTECanada and is a Canada's Top 10™ Competition winner.  

iCo trades on the TSX Venture Exchange under the symbol "ICO", and the OTCQX under the symbol “ICOTF”.

Contacts:

iCo Finance: John Meekison, CFO.  604-602-9414 meekison@icotherapeutics.com

Equicom Group: Michael Moore, Investor Relations 858-886-7813 mmoore@tmxequicom.com

Fact Sheets

News Releases

Copyright 2010 ICO Therapeutics | Disclaimer